Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease

Hippocampus

Volumn 18, Issue 7, 2008, Pages 692-698

  Li, Dabing ^a   Tang, Jun ^a   Xu, Haiwei ^a   Fan, Xiaotang ^a   Bai, Yun ^a   Yang, Li ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; ASODN; BMP4; BrdU; Hippocampus; Proliferation

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BONE MORPHOGENETIC PROTEIN 4; BROXURIDINE; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BONE MORPHOGENETIC PROTEINS; BROMODEOXYURIDINE; CELL COUNT; CELL DIVISION; CEREBRAL CORTEX; DENTATE GYRUS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDES, ANTISENSE; PRESENILIN-1; RNA, MESSENGER;

EID: 47749092769     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20428     Document Type: Article

References (45)

1. Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J, Copeland NG, Jenkins NA, Sisodia SS, Price DL. 1996a. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13:159-163.
2. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS. 1996b. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-1013.
3. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
4. Chen D, Feng JQ, Feng M, Harris MA, Mundy GR, Harris SE. 1993. Cloning and sequence of bone morphogenetic protein 4 cDNA from fetal rat calvarial cell. Biochim Biophys Acta 1174: 289-292.
5. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG. 2004. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127:601-609.
6. Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ. 2006. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 495: 70-83.
7. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
8. Eucher JN, Uemura E, Sakaguchi DS, Greenlee MHW. 2007. Amyloid-beta peptide affects viability but not differentiation of embryo and adult rat hippocampal progenitor cells. Exp Neurol 203:486-492.
9. Fan XT, Xu HW, Cai WQ, Yang Z, Zhang JH. 2003. Spatial and temporal patterns of expression of Noggin and BMP4 in embryonic and postnatal rat hippocampus. Dev Brain Res 146:51-58.
10. Fan XT, Xu HW, Cai WQ, Yang H, Liu SY. 2004. Antisense Noggin oligodeoxynucleotide administration decreases cell proliferation in the dentate gyrus of adult rats. Neurosci Lett 366:107-111.
11. Feng R, Rampon C, Tang YP, Shrom D, Jin J, Kyin M, Sopher B, Miller MW, Ware CB, Martin GM, Kim SH, Langdon RB, Sisodia SS, Tsien JZ. 2001. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32:911-926.
12. Franklin KBJ, Paxinos G. 1997. The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press.
13. Games D, Buttini M, Kobayash D, Schenk D, Seubert P. 2006. Mice as models: Transgenic approaches and Alzheimer's disease. J Alzheimers Dis 9:133-149.
14. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP. 2006. Characterization of amyloid deposition in the APPswe/ PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24: 516-524.
15. Harland R. 2000. Neural induction. Curr Opin Genet Dev 10:357-362.
16. Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP. 2002. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 83:1509-1524.
17. Jankowsky JL, Fadale DL, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13:159-170.
18. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV. 2005. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25:5217-5224.
19. Kempermann G, Kuhn HG, Gage FH. 1997. More hippocampal neurons in adult mice living in an enriched environment. Nature 386:493-495.
20. Kempermann G, Gast D, Kronenberg G, Yamaguchi M, Gage FH. 2003. Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 130:391-399.
21. Kempermann G, Jessberger S, Steiner B, Kronenberg G. 2004. Milestones of neuronal development in the adult hippocampus. Trends Neurosci 27:447-452.
22. Kralic JE, Ledergerber DA, Fritschy JM. 2005. Disruption of the neurogenic potential of the dentate gyrus in a mouse model of temporal lobe epilepsy with focal seizures. Eur J Neurosci 22:1916-1927.
23. Kulessa H, Turk G, Hogan BL. 2000. Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicle. EMBO J 19:6664-6674.
24. Lazarov O, Lee M, Peterson DA. Sisodia SS. 2002. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22:9785-9793.
25. Lee MK, Borchelt DR, Kim G, Thinakaran G, Slunt HH, Ratovitski T, Martin LJ, Kittur A, Gandy S, Levey AI, Jenkins N, Copeland N, Price DL, Sisodia SS. 1997. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat Med 3:756-760.
26. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, García-Verdugo JM, Alvarez-Buylla A. 2000. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 28:713-726.
27. Lipkind D, Nottebohm F, Rado R, Barnea A. 2002. Social change affects the survival of new neurons in the forebrain of adult song-birds. Behav Brain Res 133:31-43.
28. Luo Y, Sunderland T, Roth GS, Wolozin B. 1996. Physiological levels of beta-amyloid peptide promote PC12 cell proliferation. Neurosci Lett 217:125-128.
29. Mabie PC, Mehler MF, Kessler JA. 1999. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19:7077-7088.
30. McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP. 1998. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 12:1438-1452.
31. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
32. Price DL. 1986. New perspectives on Alzheimer's disease. Annu Rev Neurosci 9:489-512.
33. Price DL, Sisodia SS. 1998. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21:479-505.
34. Price DL, Tanzi RE, Borchelt DR, Sisodia SS. 1998. Alzheimer's disease: Genetic studies and transgenic models. Annu Rev Genet 32: 461-493.
35. Ragsdale CW, Grove EA. 2001. Patterning the mammalian cerebral: cortex. Curr Opin Neurobiol 11:50-58.
36. Reiserer RS, Harrison FE, Svverud DC, McDonald MP. 2007. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 6:54-65.
37. Schmitt JM, Hwang K, Winn SR, Hollinger JO. 1999. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthop Res 17:269-278.
38. Selkoe DJ, Kopan R. 2003a. Notch and presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26:565-597.
39. Selkoe DJ, Schenk D. 2003b. Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545-584.
40. Shors TJ, Townsend DA, Zhao M, Kozorovitskiy Y, Gould E. 2002. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12:578-584.
41. Suzuki S, Gerhold LM, Böttner M, Rau SW, Cruz CD, Yang E, Zhu H, Yu J, Cashion AB, Kindy MS, Merchenthaler I, Gage FH, Phyllis M, Wise PM. 2007. Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta. J Comp Neurol 500:1064-1075.
42. Wang R, Dineley KT, Sweatt JD, Zheng H. 2004. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 126:305-312.
43. Watt FM, Hogan BL. 2000. Out of Eden: Stem cells and their niches. Science 287:1427-1430.
44. Wisniewski HM, Terry RD. 1973. Re-examination of the pathogenesis of the senile plaque. In: Zimmerman HM, editor. Progress in Neuropathology. New York: Grune and Stratton. p 1-26.
45. Yin JB, Ma YX, Yin Q, Xu HW, An N, Liu SY, Fan XT, Yang H. 2007. Involvement of over-expressed BMP4 in pentylenetetrazol kindling-induced cell proliferation in the dentate gyrus of adult rats. Biochem Bioph Res Co 355:54-60.